logo

Hikma Pharmaceuticals Plc (HIK)



Trade HIK now with
  Date
  Headline
11/3/2022 3:11:30 AM Hikma Pharma Still Sees Injectables Revenue Growth In Mid To High-single Digits For Full Year
9/30/2022 2:14:17 AM Hikma Appoints Victoria Hull And Laura Balan As Directors
8/4/2022 2:17:37 AM Hikma Pharma H1 Core Basic EPS 92.1c Vs 96.5c Last Year
5/24/2022 2:16:22 AM Hikma Pharma: Siggi Olafsson Resigns As CEO
5/5/2022 2:24:54 AM Hikma Pharma: Jazz Now Expects Authorized Generic Entry Of Xyrem To Occur In Late 2022, Or Possibly Even January 2023
4/21/2022 9:37:03 AM Hikma Completes Acquisition Of Custopharm
4/20/2022 2:33:56 AM Hikma Pharma Confirms FTC Preliminary Approval For Custopharm
4/20/2022 2:07:35 AM Hikma Confirms Received Preliminary Approval From US FTC And Now Work Towards Closing Acquisition Of Custopharm
2/24/2022 2:29:16 AM Hikma Pharma Says Pamela Kirby Not To Stand For Re-election At Next AGM
2/24/2022 2:25:19 AM Hikma Pharma FY Core Basic EPS 194.8c Vs 172.9c Last Year
2/3/2022 2:08:49 AM Hikma Completes Acquisition Of Teligent Sterile Injectable Assets
1/17/2022 2:11:34 AM Hikma Pharma Agrees To Buy Canadian Assets Of Teligent For $45.75 Mln